All In Biotech

Drug Trial Radar · NCT07185776

A Study of HRS-5632 in Adult Participants With Elevated Lipoprotein(a) at High Risk for Cardiovascular Events

A Randomized, Double-Blind, Placebo-Controlled Phase II Clinical Study to Evaluate the Efficacy and Safety of HRS-5632 Injection in Adult Patients at High Risk of Cardiovascular Events With Elevated Lipoprotein(a)

Last checked: Nov 20, 2026Latest source record: Mar 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingRandomized with 203 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

203

Actual

Start

Oct 21, 2025

Primary completion

Apr 2027

Study completion Oct 2027

Sponsor

Sponsor type
Industry
First posted
Sep 22, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The main purpose of this study is to evaluate the efficacy and safety of HRS-5632 in adult participants with elevated Lipoprotein(a) (Lp(a)) at high risk for cardiovascular events.

Conditions

  • Lipoprotein Disorder

Interventions

  • HRS-5632 InjectionDrug

    HRS-5632 injection.

  • HRS-5632 Injection PlaceboDrug

    HRS-5632 injection placebo.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The percent change from the baseline in Lipoprotein (a) (Lp(a)).Time frame: From baseline to Day 360.

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • The Second Affiliated Hospital of AFMU

    Xi’an, Shanxi, China

  • The First Affiliated Hospital of Xi'an Jiaotong University

    Xi’an, Shanxi, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.